PROK Latest Headlines

Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability

at www.tipranks.com (Fri, 20-Mar 2:01 AM)

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)

at www.tipranks.com (Thu, 19-Mar 9:20 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), HeartFlow, Inc. (HTFL) and Arvinas Holding Company (ARVN)

at www.tipranks.com (Thu, 19-Mar 7:17 AM)

ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating

at www.tipranks.com (Thu, 19-Mar 7:15 AM)

Guggenheim Sticks to Its Buy Rating for ProKidney (PROK)

at www.tipranks.com (Thu, 19-Mar 6:56 AM)

Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Dogwood Therapeutics (DWTX) and Precision BioSciences (DTIL)

at www.tipranks.com (Thu, 19-Mar 6:33 AM)

ProKidney GAAP EPS of -$0.52 beats by $0.18, revenue of $0.89M beats by $0.35M

at seekingalpha.com (Wed, 18-Mar 4:13 PM)